USPTO serial 97924895
OSTEOADAPT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 18, 2025
- Examiner
- RITTNER, HANNO I
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with OSTEOADAPT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christine K. Au-Yeung
Christine K. Au-Yeung WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL ROADPALO ALTO, CA 94304United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | therapeutic proteins for medical use in vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, immuno-oncology, orthopedic oncology, and chemotherapeutics; pharmaceutical and medicinal preparations and substances, namely, therapeutic proteins used for vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, immuno-oncology, orthopedic oncology, and chemotherapeutics | ACTIVE | Apr 11, 2024 |
| 042 | research and development in connection with protein therapies for use in pharmaceutical products orthopedic oncology, and immuno-oncology; medical research and product development in the fields of biotechnology, drug discovery, pharmaceuticals, scientific research, orthopedic oncology, immuno-oncology and protein therapeutics; development of therapeutics, namely, pharmaceutical and medical therapies for use in vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, orthopedic oncology, immuno-oncology and chemotherapeutics; scientific research and development | ACTIVE | Sep 11, 2024 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Theradaptive, Inc.
- Other trademarks owned by Theradaptive, Inc.
- Other trademarks owned by Theradaptive, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named OSTEOADAPT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 18, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 18, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 30, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Oct 30, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 29, 2025 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 5, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 7, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 7, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 7, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 6, 2025 | IUAF | USE AMENDMENT FILED | — |
| May 6, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 6, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 7, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 7, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 6, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 6, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 7, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 12, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 12, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 21, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 21, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 1, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 1, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 6, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 11, 2023 | NWAP | NEW APPLICATION ENTERED | — |